Healthpeak Properties, Inc.: Form 10-Q for the period ended Jun 30, 2022
Filed with the SEC on Aug 3, 2022 and accepted by EDGAR at Aug 3, 2022, 16:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-04-01 to 2022-06-30 | $125.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2022-01-01 to 2022-06-30 | $246.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-04-01 to 2022-06-30 | $215.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2022-01-01 to 2022-06-30 | $422.3m | us-gaap:CostOfGoodsAndServicesSold |
| Interest expense | 3 months2022-04-01 to 2022-06-30 | $41.9m | us-gaap:InterestExpense |
| Interest expense | 6 months2022-01-01 to 2022-06-30 | $79.5m | us-gaap:InterestExpense |
| Income tax | 3 months2022-04-01 to 2022-06-30 | −$718.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-01-01 to 2022-06-30 | $59.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-04-01 to 2022-06-30 | $68.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-01-01 to 2022-06-30 | $140.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-04-01 to 2022-06-30 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2022-01-01 to 2022-06-30 | $0.26 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-04-01 to 2022-06-30 | $0.13 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2022-01-01 to 2022-06-30 | $0.26 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-04-01 to 2022-06-30 | 539,815,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2022-01-01 to 2022-06-30 | 539,701,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2022-01-01 to 2022-06-30 | $449.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 6 months2022-01-01 to 2022-06-30 | $325.3m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2022-01-01 to 2022-06-30 | $11.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-06-30 | $73.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2022-06-30 | $15.32bn | us-gaap:Assets |
| Total liabilities | At period end2022-06-30 | $8.36bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-06-30 | $6.45bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2022-06-30 | $6.31bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-22-020616. Last ingested by Listed: Nov 5, 2026, 21:33 ET. Listed shows no prices and gives no investment advice.